|
Bladder Cancer Case Control Study of Arsenic in Water Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Bladder Cancer Case Control Study of Arsenic in Water conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Bladder Cancer Case Control Study of Arsenic in Water Clinical research trials and Bladder Cancer Case Control Study of Arsenic in Water healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Bladder Cancer Case Control Study of Arsenic in Water. Bladder Cancer Case Control Study of Arsenic in Water Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Bladder Cancer Case Control Study of Arsenic in Water clinical trial. Test subjects typically receive the most effective healthcare possible for their Bladder Cancer Case Control Study of Arsenic in Water condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "B" Clinical Trials Conditions > Bladder Cancer Case Control Study of Arsenic in Water  Bladder Cancer Case Control Study of Arsenic in Water
Bladder Cancer Case Control Study of Arsenic in Water
For Condition: Bladder Cancer
Status: Recruiting
Sponsor(s): National Institute of Environmental Health Sciences (NIEHS) ,
Synopsis: This study is examining the relationship between ingested arsenic and bladder cancer in two areas of California where a large percentage of the population was exposed to drinking water containing arsenic at low to moderate levels.
Details: Water supplies in many parts of the world contain naturally occurring arsenic. Previous studies have shown that arsenic at high doses can cause cancer of the bladder. The risk at lower doses is unknown. This study is examining the relationship between ingested arsenic and bladder cancer in central Nevada and Kings County, California, two areas where a large percentage of the population was exposed to drinking water containing arsenic at low to moderate levels. Approximately 200 people with bladder cancer and 400 people without bladder cancer will be included. Subjects are interviewed by telephone about past residences, occupations, diet, drinking water consumption, and other lifestyle factors. Arsenic measurements in well water have been collected from the appropriate state agencies and are being matched with residences and drinking water consumption rates to estimate lifetime arsenic exposures for each subject. People with bladder cancer will then be compared to those without to see if people with cancer were more likely to have lived in areas with arsenic in their drinking water.
Eligibility:
Study Type: Observational, Natural History, Longitudinal, Case Control, Retrospective Study
Minimum Age/Maximum Age: 20 Years/85 Years
Genders: Both
Protocol Entry Criteria: Cases must meet the following criteria: -Diagnosed with primary bladder cancer from January 1, 1997 until December 31, 2000. -Live in the following counties at the time of diagnosis: Churchill, Lyon, Mineral, Storey, Douglas, Carson City, Nevada, and Kings County, California -Ages 20-85 at the time of diagnosis. Controls will be matched to cases based on gender and five year age groups.
Total Enrollment: 600
Location and Contact Information:
Allan Smith Research Office *Recruiting*
Berkeley, California, 94720
United States
Recruiting Craig Steinmaus 510-843-1736
Additional Information:
Study ID Numbers: 7459-CP-001;
Study Start Date: October 1997
Record last reviewed: August 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00011518
Other Bladder Cancer Studies:
1. Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
2. Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium
3. BMS-247550 in Treating Patients With Advanced Urinary Tract Cancer
4. Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
5. Short-Term Low-Dose Interferon alfa in Treating Patients With Cancer of the Urothelium
Related Studies:
Other Bladder Cancer Clinical Trials
Other California Clinical Trials
Other Berkeley Clinical Trials
Bladder Cancer Case Control Study of Arsenic in Water
|
|
|
|
|
|
|
|
